UNLIMITED TURBO SHORT - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 07:05:31 18/06/2024 pm IST | ||
| 2.29 EUR | +0.88% |
|
| Current month | -0.44% | ||
| 1 month | +11.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 18/24/18 | 2.29 | +0.88% |
| 17/24/17 | 2.27 | +0.89% |
| 14/24/14 | 2.25 | +3.69% |
| 13/24/13 | 2.17 | -0.46% |
| 12/24/12 | 2.18 | -3.11% |
Delayed Quote Deutsche Boerse AG
Last update June 18, 2024 at 07:05 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PD5FMW |
| ISIN | DE000PD5FMW4 |
| Date issued | 03/05/2022 |
| Strike | 110.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.51 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.67 € |
|---|---|
| Lowest since issue | 0.15 € |
| Spread | 0.01 € |
| Spread % | 0.44% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.87
USD
Average target price
96.05
USD
Spread / Average Target
+10.57%
- Stock Market
- Certificates
- Certificat
